COMMUNIQUÉS West-GlobeNewswire

Fexapotide BPH Phase 3 Clinical Trial Results Published in World Journal of Urology
30/01/2018
HASBROUCK HEIGHTS, N.J., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX ) reports today that the results of Phase 3 clinical studies of Fexapotide Triflutate undertaken from 2009-2016 [...]
PCI Synthesis Submits Patent for Synthesizing Azelaic Acid
30/01/2018
NEWBURYPORT, Mass., Jan. 30, 2018 (GLOBE NEWSWIRE) -- PCI Synthesis, Inc. ( www.pcisynthesis.com ), a pharmaceutical manufacturer of new chemical entities (NCEs), generic active pharmaceutical ingredients (APIs), and [...]
Utah Medical Products, Inc. Reports Audited Financial Performance for Fourth Quarter and Year 2017
30/01/2018
SALT LAKE CITY, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Utah Medical Products, Inc. (Nasdaq: UTMD ) concluded an outstanding year in 2017 in which it harvested distribution changes that had been in the making for several [...]
INSYS Therapeutics Adds Two New Executives to Senior Management Team
30/01/2018
VP of Human Resources, Carol Summersgill; VP of Clinical Development, Dr. Ahmed Elkashef PHOENIX, Jan. 30, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY ), a leader in the development, manufacture and [...]
Amarin Prices Public Offering of American Depositary Shares
30/01/2018
BEDMINSTER, N.J. and DUBLIN, Ireland, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ) today announced the pricing of the underwritten public offering of its American Depositary Shares ("ADSs") [...]
ChartMaxx® from Quest Diagnostics Receives Document Management & Imaging Category Leader award in the 2018 ‘Best in KLAS: Software & Services Report’
30/01/2018
Secaucus, NJ, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services, announced today that its ChartMaxx ® enterprise content management solution [...]
Elite Pharmaceuticals Reports Positive Topline Results from SequestOx™ Pilot Study
30/01/2018
NORTHVALE, N.J., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP ) today reported positive topline results from a pilot study conducted for SequestOx™, Elite’s [...]
Medtronic and Philips Partner to Innovate in Lung Cancer Management
30/01/2018
Healthcare Leaders Join to Streamline and Optimize the Management of Lung Nodules DUBLIN and AMSTERDAM - January 30, 2018 - In a collective effort to improve the management of patients with lung nodules, Medtronic plc ( [...]
BLVD Centers Announces Expansion Into the Marijuana Market With a Plan to Monetize Certain Marijuana Strains, as Well as Offering Craving Management Products From Its New Marijuana Companion Product Line Weedaide™
30/01/2018
Third Quarter Financial Results; Highlights 9% Quarterly Revenue Growth; Update on Treatment Center Expansion NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES LOS ANGELES [...]
United Health Products Issues Update on HemoStyp®South Korea MFDS Application
30/01/2018
HENDERSON, Nev., Jan. 30, 2018 (GLOBE NEWSWIRE) -- United Health Products, Inc. (UHP) (OTC:UEEC), manufacturer and marketer of HemoStyp, a patented hemostatic gauze for the healthcare and wound care sectors, today [...]
Haven® Sun Protectant Approved in California
30/01/2018
DAVIS, Calif., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI), a leading provider of bio-based pest management and plant health products for agriculture, turf and ornamental and [...]
Assure Holdings Performs First Neuromonitoring Case in Louisiana
30/01/2018
PARKER, Colo., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV:IOM) (OTCQB:ARHH), a provider of intraoperative neuromonitoring (IONM) services, has performed its first [...]
IN.PACT Admiral Demonstrates Consistent and Durable Outcomes in New Two-Year Japan Data and IN.PACT Global Critical Limb Ischemia Cohort Analysis
30/01/2018
Data Presented at LINC 2018 Highlight IN.PACT Admiral as Safe and Effective Treatment Option in PAD DUBLIN and LEIPZIG - January 30, 2018 - Medtronic plc (NYSE: MDT) today added to its robust body of clinical evidence [...]
athenahealth Recognized as Top Practice Management (11-75 Physicians) Service in 2018 KLAS Report
30/01/2018
WATERTOWN, Mass., Jan. 30, 2018 (GLOBE NEWSWIRE) -- athenahealth, Inc. (NASDAQ: ATHN ), a leading provider of network-enabled services for hospital and ambulatory clients nationwide, today announced top-performing [...]
Exonics Therapeutics Appoints Roger M. Perlmutter, M.D., Ph.D., to Board of Directors
30/01/2018
CAMBRIDGE, Mass., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Exonics Therapeutics, Inc., a biotechnology company focused on developing SingleCut CRISPR technology to repair mutations causing Duchenne muscular dystrophy and other [...]
Cambrex Expands Process Research and Development Capabilities Across North America
30/01/2018
EAST RUTHERFORD, N.J., Jan. 30, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM ), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced an [...]
Tyme Announces Prostate Cancer Collaboration with Dr. Mack Roach III of UCSF
30/01/2018
NEW YORK, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (NASDAQ: TYME ), a clinical-stage biotechnology company developing cancer therapeutics, today announced that Mack Roach III, M.D., FASTRO, FACR, [...]
Nu-Med Plus, Inc. announces trading on OTCQB Marketplace
30/01/2018
SALT LAKE CITY, Jan. 30, 2018 (GLOBE NEWSWIRE) -- Nu-Med Plus, Inc. (OTCBB: NUMD ), a medical device development company announced it has begun to have its securities designated and traded as OTCQB securities which will [...]
BioDelivery Sciences Announces Launch and Availability of BELBUCA® in Canada
30/01/2018
RALEIGH, N.C., Jan. 30, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ: BDSI ) and Purdue Pharma (Canada) announced today that BELBUCA® (buprenorphine) buccal film is now commercially [...]

Pages